BeStock  
Stocks › Biotechnology › NRIX

Nurix Therapeutics NRIX

US equityMarket cap rank #2921Biotechnology
$12.85 −$0.75 (-5.51%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $12.85 0.00%
Open$13.40
Prev close$13.60
Day range$12.83 – $13.67
Volume2.43M
Market cap$1.40B
P/E (TTM)5.3
Dividend yield–

Analyst view

ConsensusBuy
Analysts9
Average target$35.33+174.9% vs. price
  • Buy 100%
Low $32.00Now $12.85Avg $35.33High $41.00

Recent rating changes

The last 20 actions on file set price targets from $25.00 to $41.00, averaging $35.05.

DateFirmRatingTarget
5 Nov 2026 H.C. Wainwright BUY $36.00
5 Nov 2026 RBC Capital BUY $35.00
4 Nov 2026 Stifel BUY $41.00
3 Nov 2026 BTIG BUY $32.00
2 Nov 2026 Piper Sandler BUY $35.00
16 Oct 2026 H.C. Wainwright BUY $36.00
15 Oct 2026 Morgan Stanley BUY $38.00
13 Oct 2026 Piper Sandler BUY $35.00
13 Oct 2026 Truist Financial BUY $33.00
13 Oct 2026 Baird BUY $36.00
13 Oct 2026 Stifel BUY $41.00
13 Oct 2026 Oppenheimer BUY $32.00
12 Oct 2026 RBC Capital BUY $35.00
10 Aug 2026 RBC Capital BUY $36.00
4 Aug 2026 Needham BUY $34.00
28 Jul 2026 Morgan Stanley BUY $38.00
27 Jul 2026 Morgan Stanley BUY $38.00
22 Jul 2026 UBS BUY $31.00
14 Jul 2026 Wells Fargo HOLD $25.00
10 Jul 2026 H.C. Wainwright BUY $34.00

Discussion

No comments yet — be the first to weigh in on NRIX.

Sign in to join the discussion.

Scroll to Top